{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "BCYC",
        "Security_Name": "Bicycle Therapeutics plc - American Depositary Shares",
        "Listing_Exchange": "Q",
        "Market_Category": "Q",
        "ETF": "N",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "N",
        "CQS_Symbol": "",
        "NASDAQ_Symbol": "BCYC",
        "NextShares": "N"
    },
    "history": [],
    "recommendationTrend": {
        "trend": [
            {
                "period": "0m",
                "strongBuy": 0,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-1m",
                "strongBuy": 4,
                "buy": 9,
                "hold": 2,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-2m",
                "strongBuy": 0,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-3m",
                "strongBuy": 0,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            }
        ],
        "maxAge": 86400
    },
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 2,
        "previousClose": 31.19,
        "open": 30.88,
        "dayLow": 30.4152,
        "dayHigh": 31.78,
        "regularMarketPreviousClose": 31.19,
        "regularMarketOpen": 30.88,
        "regularMarketDayLow": 30.4152,
        "regularMarketDayHigh": 31.78,
        "payoutRatio": 0,
        "beta": 0.7761,
        "forwardPE": -15.228156,
        "volume": 133641,
        "regularMarketVolume": 133641,
        "averageVolume": 235467,
        "averageVolume10days": 158380,
        "averageDailyVolume10Day": 158380,
        "bid": 22.47,
        "ask": 36.58,
        "bidSize": 800,
        "askSize": 900,
        "marketCap": 922268608,
        "fiftyTwoWeekLow": 12.08,
        "fiftyTwoWeekHigh": 54.8,
        "priceToSalesTrailing12Months": 56.43548,
        "fiftyDayAverage": 28.568,
        "twoHundredDayAverage": 24.709576,
        "currency": "USD",
        "fromCurrency": null,
        "lastMarket": null,
        "algorithm": null,
        "tradeable": false
    },
    "earnings": {
        "maxAge": 86400,
        "earningsChart": {
            "quarterly": [
                {
                    "date": "3Q2021",
                    "actual": -0.59,
                    "estimate": -0.61
                },
                {
                    "date": "4Q2021",
                    "actual": -0.63,
                    "estimate": -0.61
                },
                {
                    "date": "1Q2022",
                    "actual": -0.93,
                    "estimate": -0.68
                },
                {
                    "date": "2Q2022",
                    "actual": -0.9,
                    "estimate": -0.85
                }
            ],
            "currentQuarterEstimate": -0.89,
            "currentQuarterEstimateDate": "3Q",
            "currentQuarterEstimateYear": 2022,
            "earningsDate": [
                1677456000,
                1677801600
            ]
        },
        "financialsChart": {
            "yearly": [
                {
                    "date": 2018,
                    "revenue": 7136000,
                    "earnings": -21846000
                },
                {
                    "date": 2019,
                    "revenue": 13801000,
                    "earnings": -30608000
                },
                {
                    "date": 2020,
                    "revenue": 10390000,
                    "earnings": -51010000
                },
                {
                    "date": 2021,
                    "revenue": 11697000,
                    "earnings": -66819000
                }
            ],
            "quarterly": [
                {
                    "date": "3Q2021",
                    "revenue": 4333000,
                    "earnings": -14678000
                },
                {
                    "date": "4Q2021",
                    "revenue": 3771000,
                    "earnings": -18037000
                },
                {
                    "date": "1Q2022",
                    "revenue": 3860000,
                    "earnings": -27564000
                },
                {
                    "date": "2Q2022",
                    "revenue": 4378000,
                    "earnings": -26828000
                }
            ]
        },
        "financialCurrency": "USD"
    },
    "calendarEvents": {
        "maxAge": 1,
        "earnings": {
            "earningsDate": [
                1677456000,
                1677801600
            ],
            "earningsAverage": -0.89,
            "earningsLow": -1.15,
            "earningsHigh": -0.44,
            "revenueAverage": 5470000,
            "revenueHigh": 16000000
        }
    },
    "upgradeDowngradeHistory": {
        "history": [
            {
                "epochGradeDate": "2022-09-12T00:00:00.000Z",
                "firm": "Morgan Stanley",
                "toGrade": "Equal-Weight",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-08-31T00:00:00.000Z",
                "firm": "Cowen & Co.",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2022-08-22T00:00:00.000Z",
                "firm": "SVB Leerink",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-08-05T00:00:00.000Z",
                "firm": "SVB Leerink",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-08-05T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-07-28T00:00:00.000Z",
                "firm": "Barclays",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2022-05-23T00:00:00.000Z",
                "firm": "Piper Sandler",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-05-06T00:00:00.000Z",
                "firm": "SVB Leerink",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-04-13T00:00:00.000Z",
                "firm": "B. Riley Securities",
                "toGrade": "Neutral",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2022-04-12T00:00:00.000Z",
                "firm": "Needham",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-03-03T00:00:00.000Z",
                "firm": "JMP Securities",
                "toGrade": "Market Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-02-14T00:00:00.000Z",
                "firm": "Morgan Stanley",
                "toGrade": "Equal-Weight",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2021-12-17T00:00:00.000Z",
                "firm": "SVB Leerink",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2021-12-09T00:00:00.000Z",
                "firm": "Needham",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2021-10-14T00:00:00.000Z",
                "firm": "JMP Securities",
                "toGrade": "Market Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-10-08T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-09-30T00:00:00.000Z",
                "firm": "B. Riley Securities",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2021-07-15T00:00:00.000Z",
                "firm": "Canaccord Genuity",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-07-13T00:00:00.000Z",
                "firm": "Canaccord Genuity",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-05-07T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-04-20T00:00:00.000Z",
                "firm": "JMP Securities",
                "toGrade": "Market Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2021-01-15T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2020-10-12T00:00:00.000Z",
                "firm": "Cantor Fitzgerald",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2020-09-10T00:00:00.000Z",
                "firm": "Canaccord Genuity",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2020-06-12T00:00:00.000Z",
                "firm": "Oppenheimer",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2019-11-14T00:00:00.000Z",
                "firm": "Roth Capital",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2019-09-11T00:00:00.000Z",
                "firm": "Goldman Sachs",
                "toGrade": "Buy",
                "fromGrade": "Neutral",
                "action": "up"
            },
            {
                "epochGradeDate": "2019-06-17T00:00:00.000Z",
                "firm": "Piper Sandler",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2019-06-17T00:00:00.000Z",
                "firm": "Jefferies",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2019-06-17T00:00:00.000Z",
                "firm": "Goldman Sachs",
                "toGrade": "Neutral",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2019-06-17T00:00:00.000Z",
                "firm": "Canaccord Genuity",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            }
        ],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "FREE_REALTIME",
        "postMarketChangePercent": 0,
        "postMarketChange": 0,
        "postMarketTime": "2023-01-06T21:01:12.000Z",
        "postMarketPrice": 31.37,
        "postMarketSource": "DELAYED",
        "regularMarketChangePercent": 0.0057710903,
        "regularMarketChange": 0.1800003,
        "regularMarketTime": "2023-01-06T21:00:04.000Z",
        "priceHint": 2,
        "regularMarketPrice": 31.37,
        "regularMarketDayHigh": 31.78,
        "regularMarketDayLow": 30.4152,
        "regularMarketVolume": 133641,
        "averageDailyVolume10Day": 158380,
        "averageDailyVolume3Month": 235467,
        "regularMarketPreviousClose": 31.19,
        "regularMarketSource": "FREE_REALTIME",
        "regularMarketOpen": 30.88,
        "exchange": "NMS",
        "exchangeName": "NasdaqGS",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "EQUITY",
        "symbol": "BCYC",
        "underlyingSymbol": null,
        "shortName": "Bicycle Therapeutics plc",
        "longName": "Bicycle Therapeutics plc",
        "currency": "USD",
        "quoteSourceName": "Delayed Quote",
        "currencySymbol": "$",
        "fromCurrency": null,
        "lastMarket": null,
        "marketCap": 922268608
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 2,
        "enterpriseValue": 377880768,
        "forwardPE": -7.3811765,
        "profitMargins": 0,
        "floatShares": 18843747,
        "sharesOutstanding": 29399700,
        "sharesShort": 3280859,
        "sharesShortPriorMonth": 2913792,
        "sharesShortPreviousMonthDate": 1663200000,
        "dateShortInterest": 1665705600,
        "sharesPercentSharesOut": 0.1106,
        "heldPercentInsiders": 0.09847,
        "heldPercentInstitutions": 0.92332,
        "shortRatio": 16.51,
        "beta": 0.7761,
        "category": null,
        "bookValue": 6.674,
        "priceToBook": 4.70033,
        "fundFamily": null,
        "legalType": null,
        "lastFiscalYearEnd": "2021-12-31T00:00:00.000Z",
        "nextFiscalYearEnd": "2023-12-31T00:00:00.000Z",
        "mostRecentQuarter": "2022-06-30T00:00:00.000Z",
        "netIncomeToCommon": -87107000,
        "trailingEps": -2.872,
        "forwardEps": -2.06,
        "lastSplitFactor": null,
        "enterpriseToRevenue": 23.123,
        "enterpriseToEbitda": -4.434
    },
    "summaryProfile": {
        "address1": "Babraham Research Campus",
        "address2": "Building 900",
        "city": "Cambridge",
        "zip": "CB22 3AT",
        "country": "United Kingdom",
        "phone": "44 1223 261 503",
        "website": "https://www.bicycletherapeutics.com",
        "industry": "Biotechnology",
        "sector": "Healthcare",
        "longBusinessSummary": "Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The company's oncology product candidates also comprise BT5528, a BTC that is in a Phase I/II clinical trial targeting EphA2; and BT8009, which is in Phase I/II clinical trial targeting Nectin-4. In addition, it is developing THR-149, a plasma kallikrein inhibitor that completed Phase II clinical trials for the treatment of diabetic macular edema; BT7480, a Bicycle tumor-targeted immune cell agonist (TICA) targeting Nectin-4 and agonizing; BT7455, an EphA2/CD137 Bicycle TICA, which is in preclinical studies; and BT1718, a BTC that target tumors, that is in Phase I/IIa clinical trial that express Membrane Type 1 matrix metalloproteinase. Further, the company collaborates with biopharmaceutical companies and organizations to develop programs in therapeutic areas, such as anti-infective, cardiovascular, ophthalmology, and respiratory indications. It has a clinical trial and license agreement with the Cancer Research Technology Limited and Cancer Research UK; research collaboration agreements with AstraZeneca, Sanofi, Oxurion, and the Dementia Discovery Fund; and discovery collaboration and license agreement with Genentech for the discovery and development of Bicycle peptides for multiple immuno-oncology targets. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom.",
        "fullTimeEmployees": 119,
        "companyOfficers": [],
        "maxAge": 86400
    },
    "financialData": {
        "maxAge": 86400,
        "currentPrice": 31.37,
        "targetHighPrice": 74,
        "targetLowPrice": 33,
        "targetMeanPrice": 53.85,
        "targetMedianPrice": 57,
        "recommendationMean": 1.9,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 13,
        "totalCash": 372768992,
        "totalCashPerShare": 12.561,
        "ebitda": -85217000,
        "totalDebt": 45545000,
        "quickRatio": 9.652,
        "currentRatio": 9.881,
        "totalRevenue": 16342000,
        "debtToEquity": 14.626,
        "revenuePerShare": 0.576,
        "returnOnAssets": -0.16194001,
        "returnOnEquity": -0.38419998,
        "grossProfits": -33183000,
        "freeCashflow": -56457000,
        "operatingCashflow": -38648000,
        "revenueGrowth": 1.453,
        "grossMargins": -2.5248399,
        "ebitdaMargins": 0,
        "operatingMargins": -5.3237095,
        "profitMargins": 0,
        "financialCurrency": "USD"
    }
}